Mercado de cápsulas endoscópicas: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00006873
  • Category : Life Sciences
  • No. of Pages : 178
Buy Now

Capsule Endoscopy Market Key Players Analysis 2031

Buy Now

Se espera que el mercado mundial de cápsulas endoscópicas crezca desde dólares estadounidenses 465,72 millones en 2022 a US$ 757,51 millones en 2031; se estima que crecerá a una tasa compuesta anual del 8,4 % entre 2022 y 2031.

Según el informe de la Sociedad Coreana de Neurogastroenterología y Motilidad, los trastornos gastrointestinales funcionales (TFGID) son un grupo de trastornos gastrointestinales (GI) que involucran varias combinaciones de síntomas gastrointestinales (GI) crónicos o recurrentes o anomalías bioquímicas. La creciente prevalencia de trastornos gastrointestinales está impulsando el endoscopia de cápsulas < /em>crecimiento del mercado. La cápsula endoscópica (CE) también se utiliza para detectar enfermedades del intestino delgado, hemorragia gastrointestinal oscura, enfermedad celíaca, enfermedad de Crohn, tumores del intestino delgado y otras enfermedades. Dispepsia funcional (DF) y irritable El síndrome intestinal (SII) son los TGF más reconocidos. Además, la demanda de cápsula endoscópica es alta en casos relacionados con el tracto gastrointestinal, ya que la cápsula endoscópica implica el diagnóstico de hemorragia gastrointestinal oscura y anemia crónica por deficiencia de hierro, tumores del intestino delgado y evaluación de los resultados del tratamiento de la enfermedad celíaca y de Crohn. Además, la cápsula endoscópica está altamente equipada para detectar la enfermedad celíaca (EC). La enfermedad celíaca es una enfermedad autoinmune genética grave que daña las vellosidades del intestino delgado e interfiere con la absorción de nutrientes de los alimentos. El informe Beyond Celiac 2022 afirma que aproximadamente 1 de cada 133 estadounidenses, o ~1% de la población, tiene enfermedad celíaca. Además, en Finlandia, la prevalencia de la enfermedad celíaca es ~1,99% entre la población total. Además, la cápsula endoscópica es muy considerada cuando los síntomas clínicos son muy sospechosos y están relacionados con la enfermedad celíaca. Por ejemplo, la CE que modifica el curso clínico, particularmente en casos con serología positiva al inicio y en el procedimiento de cápsula endoscópica, se considera segura y útil y desempeña un papel fundamental en el diagnóstico engañoso de la EC. Por lo tanto, se espera que la afluencia de cápsulas endoscópicas para trastornos gastrointestinales impulse el crecimiento general del mercado durante el período de pronóstico.

Los avances tecnológicos en cápsula endoscópica están respaldando el crecimiento general del mercado. La afluencia de la videocápsula endoscópica (VCE) se atribuye a los continuos avances tecnológicos en imágenes. Además, la VCE basada en IA implica el diagnóstico de tumores, hemorragia gastrointestinal, enfermedad de Crohn y enfermedad celíaca. Además, los avances en la obtención de imágenes de VCE implican mejoras de hardware y software con avances en los componentes de las cápsulas que involucran la cámara, la fuente de energía y la unidad de transmisión. Se espera que las mejoras de software, como la llegada de la IA en VCE, amplíen el alcance de VCE en el campo de la biopsia óptica, convirtiéndose en una realidad clínica. Por lo tanto, la llegada de la tecnología mejora el crecimiento general del mercado de cápsulas endoscópicas durante el período de pronóstico.

Perspectivas estratégicas

< strong>Panorama regional

América del Norte representa la mayor cuota del mercado de cápsulas endoscópicas, siendo Estados Unidos el principal contribuyente al crecimiento del mercado. Aprobación de nuevos productos por parte de Food & La Administración de Medicamentos (FDA) es un factor independiente responsable del crecimiento significativo del mercado general de cápsulas endoscópicas. Por ejemplo, en noviembre de 2021, Medtronic anunció haber recibido autorización para el "sistema PillCam Small Bowel 3" por la FDA destinado a un procedimiento de endoscopia remota. El producto recientemente lanzado ofrece una opción de telesalud para visualización directa y monitoreo del intestino delgado que ayuda a detectar lesiones en el endoscopio inferior (indica la enfermedad de Crohn, detecta sangrado oscuro y otros trastornos gastrointestinales). Por lo tanto, es probable que los factores antes mencionados impulsen el crecimiento del mercado en América del Norte en los próximos años.

Información sobre el producto

Según el producto, el mercado de cápsulas endoscópicas se bifurca en cápsulas endoscópicas y componentes. El segmento de cápsulas de endoscopia tuvo una mayor participación del mercado en 2022. El crecimiento del segmento se atribuye a las ventajas asociadas con la cápsula de endoscopia para el diagnóstico y detección de afecciones de salud complejas que involucran trastornos gastrointestinales, cáncer, enfermedad de Crohn y otras pequeñas trastornos intestinales. La cápsula endoscópica puede detectar la enfermedad de Crohn a través de la inflamación de la mucosa, la extensión de la enfermedad y las estenosis. Además, la cápsula endoscópica puede detectar enfermedades en el íleon terminal con una calidad de imagen del 100% en comparación con otras tecnologías como la tomografía computarizada (TC) o la heterografía por resonancia magnética. Por lo tanto, la cápsula endoscópica es muy recomendable en pacientes con enfermedad de Crohn conocida, sospechada o recidivante. Estos lucrativos beneficios que ofrecen las cápsulas para endoscopia destinadas a afecciones de salud complejas como la enfermedad de Crohn están respaldando el crecimiento del segmento.

Mercado de endoscopia por cápsula, por producto: 2022 y 2031

 

Capsule Endoscopy Market

Las empresas que operan en el mercado de la cápsula endoscópica adoptan estrategias de innovación de productos para satisfacer las demandas cambiantes en todo el mundo. mundo, permitiéndoles mantener su marca en el mercado.

< strong>Mercado de endoscopia de cápsulas – ndash; Segmentación

Según el producto, el mercado de cápsulas endoscópicas es bifurcado en cápsula de endoscopia y componentes. El segmento de cápsulas endoscópicas tuvo una mayor participación de mercado en 2022. Según la formulación, el mercado de cápsulas endoscópicas se divide en tabletas y cápsulas. El segmento de cápsulas tuvo una mayor participación de mercado en 2022. Según la aplicación, el mercado de cápsulas endoscópicas se segmenta en hemorragia gastrointestinal oscura (OGIB), enfermedad de Crohn, enfermedades del intestino delgado y otras enfermedades. Según el usuario final, el mercado se segmenta en hospitales, clínicas, centros de investigación y otros usuarios finales. Los hospitales tenían la mayor participación del mercado en 2022. Según la geografía, el mercado está segmentado principalmente en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica.

Perfiles de empresas

  • RF Co.,Ltd.
  • JINSHAN Science & Tecnología
  • SHANGXIAN MINIMAL INVASIVE INC
  • CapsoVision
  • Check-Cap.
  • INTROMEDIC
  • Medtronic
  • Olympus Corporation
  • Anhan Technology (Wuhan) Co., Ltd.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the complications associated with the use of capsule endoscopy?

Despite accuracy, speed, safety, high resolutions, non-invasiveness factors such as lack of guided navigation and less battery life are among the major limitations associated with these systems.

What are the factors driving the growth of the capsule endoscopy market?

The demand for noninvasive screening method for inspection of gastrointestinal tract is expected to grow at a significant pace during the forecast period. Some of the prime factors propelling the growth of the market include increasing prevalence of small bowel diseases and technological advancements in endoscopy are propelling the growth of the market.

What is capsule endoscopy?

Capsule endoscopes are tiny wireless endoscopy systems which are used to capture images of the internal tracts in the body. The endoscope camera fits in the vitamin size capsule and enables to take thousands of images which are then transmitted to the recorder. Capsule endoscopes allows the physicians to take the images of the parts where the traditional endoscope is unable to reach.

The List of Companies - Capsule Endoscopy Market

  1. RF Co.,Ltd
  2. JINSHAN Science & Technology
  3. Shangxian Minimal Invasive Inc.
  4. CapsoVision, Inc.
  5. Check-Cap
  6. IntroMedic Co.,Ltd.
  7. Medtronic
  8. Olympus Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..